Smac Mimetic Compounds Potentiate Interleukin-1ß-mediated Cell Death

Cheung HH, etc
J Biol Chem, 2010


Smac mimetic compounds (SMCs) potentiate TNFa-mediated cancer cell death by targeting the inhibitor of apoptosis (IAP) proteins. In addition to TNFa, the tumor microenvironment is exposed to a number of pro-inflammatory cytokines, including IL-1ß. Here, we investigated the potential impact of IL-1ß on SMC-mediated death of cancer cells. Synergy was seen in a subset of a diverse panel of 21 cancer cell lines to the combination of SMC and IL-1ß treatment, which required IL-1ß-induced activation of the NF-¿B pathway. Elevated NF-¿B activity resulted in the production of TNFa, which led to apoptosis dependent on caspase-8 and RIP1. In addition, concurrent silencing of cIAP1, cIAP2, and X-linked IAP by siRNA was most effective for triggering IL-1ß-mediated cell death. Importantly, SMC-resistant cells that produced TNFa in response to IL-1ß treatment were converted to an SMC-sensitive phenotype by c-FLIP knockdown. Reciprocally, ectopic expression of c-FLIP blocked cell death caused by combined SMC and IL-1ß treatment in sensitive cancer cells. Together, our study indicates that a positive feed-forward loop by pro-inflammatory cytokines can be exploited by SMCs to induce apoptosis in cancer cells.

Read more »

Journal
J Biol Chem
Year
2010
Page
40612-23
Institute
Children's Hospital of Eastern Ontario Research Institute